Barriers in Oligometastasis Care in Korea: Radiation Oncologists' Perspectives

Affiliations

¹ Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
² Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
³ Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Editorial

Eui Kyu Chie et al. Cancer Res Treat. 2023 Oct.

. 2023 Oct;55(4):1063-1064.

doi: 10.4143/crt.2023.780. Epub 2023 Jun 27.

¹ Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
² Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
³ Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

No abstract available

Conflict of interest statement

Conflicts of Interest

Conflict of interest relevant to this article was not reported.

1. Cho WK. Customized RT in oligometastasis. 49th Annual Meeting of Korean Cancer Association & 9th International Cancer Conference; 2023 Jun 15–16; Seoul, Korea.
1. Cho WK, Yoo GS, Rim CH, Jeong JU, Chie EK, Ahn YC, et al. Differential perspectives by specialty on oligometastatic colorectal cancer: a Korean-Oligometastasis Working Group’s comparative survey study. Cancer Res Treat. 2023;55:1281–90. - PMC - PubMed
1. Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, et al. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol. 2020;21:e18–28. - PubMed
1. Ministry of Health and Welfare. National health insurance, act No. 32748 (2022 Jun 30). Republic of Korea.
1. Ministry of Health and Welfare. Enforcement decree of the national health insurance, act No. 18895 (2022 Jun 10). Republic of Korea.